Regeneron Pharmaceuticals (REGN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2015 | 12-2014 | 12-2013 | 12-2012 | 12-2011 | |
| Sales | 4,103,728 | 2,819,557 | 2,104,745 | 1,378,477 | 445,824 |
| Cost of Goods | 392,709 | 205,018 | 155,355 | 84,455 | 4,216 |
| Gross Profit | 3,711,019 | 2,614,539 | 1,949,390 | 1,294,022 | 441,608 |
| Operating Expenses | 2,459,812 | 1,790,638 | 1,206,695 | 836,764 | 646,983 |
| Operating Income | 1,251,916 | 823,919 | 743,050 | 457,713 | -205,159 |
| Interest Expense | 14,241 | 37,372 | 46,437 | 45,304 | 21,282 |
| Other Income | -12,578 | -25,312 | -231 | 2,012 | 3,549 |
| Pre-tax Income | 1,225,097 | 761,235 | 696,382 | 414,421 | -222,892 |
| Income Tax | 589,041 | 423,109 | 282,644 | -335,848 | -1,132 |
| Net Income Continuous | 636,056 | 338,126 | 413,738 | 750,269 | -221,760 |
| Net Income | $636,056 | $338,126 | $413,738 | $750,269 | $-221,760 |
| EPS Basic Total Ops | 6.17 | 3.36 | 4.23 | 7.92 | -2.45 |
| EPS Basic Continuous Ops | 6.17 | 3.36 | 4.23 | 7.92 | -2.45 |
| EPS Diluted Total Ops | 5.52 | 2.98 | 3.72 | 6.75 | -2.45 |
| EPS Diluted Continuous Ops | 5.52 | 2.98 | 3.72 | 6.50 | -2.45 |
| EBITDA(a) | $1,326,825 | $876,605 | $784,254 | $494,653 | $-174,077 |